Venture Capital: Allozyne raises $30M for MS drug
| October 26, 2007 |  View for printing |
Allozyne http://www.allozyne.com/ has raised a whopping $30 million in venture funding, money that the Seattle biotechnology upstart will use to develop a new multiple sclerosis treatment that could reduce the number of injections for patients from every other day to every other week.
By JOHN COOK P-I REPORTER
Full Story: http://seattlepi.nwsource.com/ventur ... 1_vc26.html
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
